4//SEC Filing
Javitt Daniel C. 4
Accession 0000880984-22-000014
CIK 0001719406other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 7:40 PM ET
Size
4.9 KB
Accession
0000880984-22-000014
Insider Transaction Report
Form 4
Javitt Daniel C.
10% Owner
Transactions
- Sale
common stock
2022-11-11$1.01/sh−49,200$49,510→ 9,823,701 total(indirect: By LLC)
Footnotes (2)
- [F1]Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022.
- [F2]Held by Glytech LLC of which the Reporting Person is the sole owner.
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001864534
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 7:40 PM ET
- Size
- 4.9 KB